HIV Prevention Intervention for Young Transgender Women (LifeSkills)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 24, at risk for HIV acquisition or transmission.
| Condition | Intervention |
|---|---|
|
Sexual Transmission of Infection |
Behavioral: HIV prevention intervention Behavioral: Diet and Nutrition Other: Standard of care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | HIV Prevention Intervention for Young Transgender Women |
- Change from baseline in number of unprotected anal sex acts in the previous 4 months [ Time Frame: Baseline, 4-months post-intervention ] [ Designated as safety issue: No ]Self-reported unprotected anal sex acts in the previous 4 months assessed via computer-assisted self-interviewing.
| Estimated Enrollment: | 375 |
| Study Start Date: | March 2012 |
| Estimated Study Completion Date: | March 2016 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: HIV group-based prevention intervention
The intervention is a 6-session group-based and manualized intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
|
Behavioral: HIV prevention intervention
The 6-session HIV prevention intervention curriculum, "LifeSkills," incorporates interactive activities, in-depth discussions, videos, games, and role-plays to help young transgender women develop, practice, and integrate new skills into "real-life" situations. Activities address each aspect our theoretical framework (information, motivation, behavior), including experiences that may pre-dispose young transgender women to HIV/STI risk.
|
|
Active Comparator: Diet and nutrition
The comparison condition is a 6-session group-based and manualized health promotion intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
|
Behavioral: Diet and Nutrition
The comparison condition is a 6-session group-based and manualized health promotion intervention. Participants will also receive HIV and STI testing and counseling prior to the start of the intervention.
|
|
No Intervention: Standard-of-care
This arm will receive HIV and STI testing and counseling only.
|
Other: Standard of care
This arm will receive HIV and STI testing and counseling only.
|
Detailed Description:
The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 24, at risk for HIV acquisition or transmission. The study will test this intervention in a three-arm randomized controlled trial in two major U.S. cities with excellent access to and research experience with the population (Chicago, Boston). We will enroll 375 at risk YTW, ages 16-24; two-fifths of the sample (N=150) randomized to the intervention will participate in the 6-session group-based and manualized Life Skills intervention; two-fifths (N=150) will be randomized to the standard-of-care (SOC) control condition; and one-fifth will be randomized to the time-matched attention control condition (N=75) and receive standard health promotion information in a group-based multi-session format. All three arms will receive HIV and STI (Chlamydia and gonorrhea) testing and pre-posttest risk reduction counseling (i.e., SOC). Sexual risk will be assessed at baseline, 4, 8 and 12 months post-intervention Our specific aims are: 1) to determine the efficacy of the Life Skills intervention in comparison to a SOC arm and a time-matched attention control on the primary outcome: number of unprotected anal sex acts (UAS) (in the previous four months) among YTW, ages 16-24; and 2) to examine the degree to which improvements in sexual risk taking are mediated by the conceptual mediators of the intervention: transgender adaptation and integration, collective self-esteem/empowerment, information (HIV knowledge), motivation (attitudes, norms, and intentions for safer sex), and behavioral skills (discussing sex and condom use with sexual partners, acquiring and using condoms); and to explore whether reductions in sexual risk are associated with epidemiologically-linked moderators of sexual risk behavior: age, race/ethnicity, and psychosocial factors. An additional exploratory aim is to describe the prevalence of HIV and STIs in the community recruited sample; in the SOC arm, we will assess the natural trajectory of sexual risk behavior and the acquisition of HIV and STIs (incidence rate) in YTW over a 12-month follow-up period.
Eligibility| Ages Eligible for Study: | 16 Years to 24 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age 16-24
- self-identified as transgender, transsexual, and/or female with a male biological or birth sex
- self-reported history of unprotected anal or vaginal intercourse with a male partner in previous 4 months
- able to speak and understand English
- willing and able to provide informed consent/assent
- intention to reside in the local area throughout the 12 month follow-up period
Exclusion Criteria:
- unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
- active suicidal ideation at the time of baseline interview
Contacts and Locations| Contact: Robert Garofalo, MD | 773-880-4551 | rgarofalo@childrensmemorial.org |
| United States, Illinois | |
| Children's Memorial Hospital | Recruiting |
| Chicago, Illinois, United States, 60614 | |
| Principal Investigator: Robert Garofalo, MD | |
| United States, Massachusetts | |
| The Fenway Institute | Recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: Matthew Mimiaga, Sc.D. | |
| Principal Investigator: Matthew Mimiaga, Sc.D. | |
| Principal Investigator: | Robert Garofalo, MD | Ann & Robert H Lurie Children's Hospital of Chicago |
More Information
Additional Information:
Publications:
| Responsible Party: | Ann & Robert H Lurie Children's Hospital of Chicago |
| ClinicalTrials.gov Identifier: | NCT01575938 History of Changes |
| Other Study ID Numbers: | R01MH094323, R01MH094323 |
| Study First Received: | March 29, 2012 |
| Last Updated: | April 12, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by Ann & Robert H Lurie Children's Hospital of Chicago:
|
HIV infection |
ClinicalTrials.gov processed this record on June 18, 2013